endogene.bio’s research platform helps discover molecular biomarkers to better diagnose and stratify patients, and to improve drug discovery processes using menstrual blood. The company work with analytical laboratories to provide diagnostic tests and we assist pharmaceutical companies in optimizing drug development and patient stratification for clinical trials. They address the historical underrepresentation of female biology in medical research and bring precision medicine to female health.